Enhanced Recovery After Surgery (ERAS) In Thoracoscopic Radical Lung Cancer Surgery

Objective: In recent years,the incidence of lung cancer has gradually increased,and the mortality rate is the highest among all cancers.Thoracoscopic radical lung cancer surgery has been recommended as a routine surgical method for lung cancer.The concept of enhanced recovery after surgery(ERAS)refers to the use of a series of positive interventions based on evidence-based medicine before,during,and after surgery,and minimally invasive surgery.Periodic nursing measures are optimized.This article explores the clinical effects and feasibility of ERAS in the application of thoracoscopic lung cancer radical operation.Methods: A retrospective analysis of clinical records of 120 patients with lung cancer in our hospital from September 2017 to February 2020.According to the different treatment concepts and treatment measures of patients during perioperative period,they were divided into ERAS group and control group,with 60 cases in each group.The differences in Visual Analogue Score(VAS),pulmonary function,incidence of postoperative complications,length of stay,cost of hospitalization,and nursing satisfaction were compared between the two groups of patients.The data were analyzed statistically using SPSS 25.0 software.Among them measurement data: mean ± standard deviation(x ± s),using t test of two independent samples for comparison between groups;count data: actual number of cases and percentage(%),using X2 test for comparison between groups.P <0.05 was considered statistically significant.Results: Patients in the two groups were compared in terms of age,gender,BMI,smoking history,preoperative combined disease,tumor resection site,TNM stage(according to the International Union Against Cancer Eighth Edition staging criteria for lung cancer).There was no significant difference(P> 0.05).At the same time,there was no statistically significant difference in the general information such as operation time,total blood loss,and number of lymph node dissections between the two groups(P> 0.05).Compared with VAS scores on the 1st,3rd and 7th days afteroperation,the ERAS group was smaller than the control group,and the difference was statistically significant(P <0.05).Preoperative lung function indicators(FEV1,FEV1%,FVC,FVC%,MVV,and MVV%)were not significantly different between the two groups(P> 0.05);however,lung function levels were better in the ERAS group on the third day after surgery.In the control group,the difference was statistically significant(P <0.05).On the seventh day after surgery,the two groups were compared again.The lung function level of the ERAS group was still better than that of the control group,and the difference was statistically significant(P <0.05).The incidence of atelectasis and pulmonary infection in the ERAS group was less than that in the control group,and the differences were statistically significant(P <0.05).However,there was no significant difference in the incidence of pleural effusion,incision infection,thrombosis,and arrhythmia between the ERAS group and the control group(P> 0.05).Hospital stay was shorter in the ERAS group than in the control group,and the difference was statistically significant(P <0.05).The hospitalization cost of the ERAS group was significantly lower than that of the control group,and the difference was statistically significant(P <0.05).In terms of nursing satisfaction,the comprehensive satisfaction score of patients in the ERAS group significantly improved,and the difference was statistically significant(P <0.05).Conclusion: Compared with traditional treatment,the application of ERAS in thoracoscopy radical surgery for lung cancer can reduce postoperative pain,help patients with rapid recovery of lung function,reduce postoperative complications,reduce hospitalization time,hospitalization costs,and improve patient satisfaction.degree.ERAS has great development potential and is worthy of clinical promotion.